Allotment process begins for heavily subscribed Sudeep Pharma IPO

Sudeep Pharma’s IPO allotment is being finalised after strong demand pushed overall subscription to 93.71 times, led by exceptional QIB participation and broad interest across investor categories.

positive
Recently

Allotment process begins for heavily subscribed Sudeep Pharma IPO

1 min read57 words
Allotment process begins for heavily subscribed Sudeep Pharma IPO
Sudeep Pharma’s IPO allotment is being finalised after strong demand pushed overall subscription to 93.
Share allocation for the Sudeep Pharma IPO is scheduled to be finalised today following exceptionally strong demand during the three day subscription period that closed on November 25. The public issue recorded an overall subscription of 93.71 times, driven by notably high participation across investor categories. Retail investors subscribed 15.65 times, while non-institutional bidders reached 116.72 times
Sentinel